SAN DIEGO, April 13, 2011 /PRNewswire/ -- BioLegend, Inc., a provider of antibodies and reagents for biomedical research, announced today the release of over fifty Brilliant Violet 421™ antibody ...
SARASOTA, FL, UNITED STATES, January 28, 2026 /EINPresswire.com/ — Identifyn ®, a leader in super-resolution applications and discovery tools, is proud to announce ...
In recent years, antibodies have become an incredibly popular therapeutic target – with monoclonal antibodies (mAbs) becoming an ever more widely used therapy for a number of diseases, including ...
Multiplexed, multiparameter screening assays are foundational to the drug discovery process. By collecting more information, more rapidly – whether the focus antibodies, small molecules, or phenotypic ...
The past decade has seen an explosion in the number of antibody-based therapeutics on the market. A huge driver of this has been the advancement of technologies that improve the time and efficiency of ...
Recent advances in analytical techniques have increased the efficiency of therapeutic antibody discovery and facilitated rapid growth of the mono-clonal antibody (mAb) market over the past 25 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results